Trinity College Institute of Neuroscience bequest. I want to cover Psychiatric; Traumatic Brain Injury, Anxiety, Cognitive deficits, Dementia

Thought for 38s

Trinity College Dublin’s Institute of Neuroscience (TCIN) is an excellent place to direct a bequest supporting research into psychiatric disorders and anxiety following traumatic brain injury (TBI). TCIN is Trinity’s dedicated interdisciplinary neuroscience research institute, bringing together

~50 principal investigators and

~250 researchers from psychology, psychiatry, physiology, pharmacology, medicine, biochemistry, engineering, genetics, and related fields.

tcd.ie It focuses on basic and translational research (from molecules to mind and patient care), with strengths in neuropsychiatry/neurodevelopmental disorders, synapses/cognition/behaviour, neurodegeneration, neuroprotection/neurorepair, imaging, and clinical collaborations. Clinical principal investigators are based at hospitals including St Patrick’s (psychiatry), St James’s, and Tallaght, providing access to patient populations, biosamples, and facilities like advanced MRI (human and small animal) and clinical neuroimaging/trials infrastructure.

tcd.ie TCIN’s work aligns well with psychiatric conditions and post-TBI anxiety through its neuropsychiatry focus, translational/clinical links, neuroimaging capabilities (relevant for studying brain changes after injury), and broader themes in brain injury, inflammation, and neurorepair. While it does not appear to have a single named “TBI anxiety” program, its interdisciplinary and patient-oriented approach positions it strongly to advance understanding and potential interventions in these areas (e.g., via mechanisms linking injury, inflammation, and psychiatric outcomes). Making a Bequest (Legacy Gift) to TCINBequests are a powerful, tax-efficient way to support this work.

In Ireland, legacies to Trinity College Dublin (charity number CHY10898) are generally exempt from Capital Acquisitions Tax (CAT/inheritance tax), so 100% of the gift can go to the intended purpose. Similar benefits or structures apply in the UK (via the UK Trust, charity number 280693) and other jurisdictions.Important: This is general information only—not legal, tax, or financial advice. Wills are legal documents, and requirements vary by country/jurisdiction. Always consult a qualified solicitor (and possibly a tax advisor or estate planner) to draft or amend your will properly. They can ensure the wording is valid, tax-efficient, and reflects your exact wishes.

Recommended Steps

1. Consult your solicitor early. Discuss your overall estate plan and how to include a gift to Trinity.
2. Decide on the type of gift:
   • Residuary (a percentage or share of the remainder of your estate after other gifts/debts)—often flexible and recommended.
   • Pecuniary (a fixed sum of money).
   • Specific (e.g., shares, property, or another asset).
3. Specify the purpose clearly so the gift supports TCIN and your priority areas (psychiatric disorders and TBI-related anxiety). Trinity allows donors to direct gifts to particular areas where possible.
4. Optionally inform Trinity in advance (non-binding and confidential). This helps them plan, confirm the gift can be directed as you wish, and welcome you into the 1592 Circle (their society recognizing legacy pledgers, with optional recognition, updates on impact, and events).

Sample Wording (Ireland-focused; adapt as needed). These are illustrative examples only—your solicitor must customize them. A common structure is:

“I give [the whole / a % share of] the residue of my estate / the sum of €__ (in figures and words) to Trinity College Dublin (Charity Number CHY10898) to be used for the Trinity College Institute of Neuroscience (TCIN), with a preference for supporting research into psychiatric disorders and anxiety associated with traumatic brain injury. I direct that the receipt of the Treasurer of Trinity College shall be a sufficient discharge to my Executor(s).”

For UK donors, gifts are typically routed through the UK Trust for Trinity College Dublin (charity number 280693) with adapted wording. US donors can gift directly to Trinity College Dublin. Your solicitor can provide jurisdiction-specific versions and handle any codicil (amendment) to an existing will.Trinity’s legacy materials emphasize flexibility and that you can indicate preferences for specific areas (e.g., an institute or research theme).

tcd.ie Key Contacts

• For TCIN/research discussion (e.g., current priorities, how funds could support psychiatric/TBI-anxiety work, or impact updates):
  neuroscience@tcd.ie (mailto:neuroscience@tcd.ie)
  Tel: +353 1 896 8484
  Trinity College Institute of Neuroscience, Room 3.05, Lloyd Building, Trinity College Dublin, Dublin 2, Ireland.
  Director: Professor Rhodri Cusack; Deputy Director: Professor Andrew Harkin.
• For legacies/bequests and the 1592 Circle (Trinity Development & Alumni):
  alumni@tcd.ie (mailto:alumni@tcd.ie) or specific legacy team members (they can connect you).
  Tel: +353 1 896 2088
  Trinity Development & Alumni, East Chapel, Trinity College Dublin, Dublin 2, Ireland.
  Legacy information and resources: Search “leave a legacy” or visit tcd.ie/alumni (or tcd.ie/campaign/leave-a-legacy).

You can request suggested wording tailored to your situation or discuss directing the gift precisely. Informing them of your intentions (even early-stage) is welcomed and helps ensure smooth administration. Leaving a legacy in this area can have lasting impact—advancing understanding of complex conditions like post-TBI anxiety and psychiatric disorders through world-class interdisciplinary neuroscience at Trinity. If you share more details (e.g., your location for jurisdiction-specific info or specific aspects you’d like clarified), I can help refine this further or point to additional resources. Please consult professionals for personalized guidance.

2 web pages

Explore neuroinflammation links to TBI anxiety

Investigate Trinity’s St Patrick’s Hospital psychiatry

Investigate Trinity’s St Patrick’s Hospital psychiatry

Thought for 34s

Trinity College Dublin (TCD) has a deep, longstanding, and active affiliation with St Patrick’s Mental Health Services (SPMHS), particularly its flagship St Patrick’s University Hospital (SPUH) in Dublin. This partnership integrates clinical care, teaching, and research in psychiatry, with strong ties to TCD’s Discipline of Psychiatry (also referred to as the Department or School of Psychiatry) and the Trinity College Institute of Neuroscience (TCIN).

tcd.ie Historical Background

St Patrick’s traces its roots to 1746, when it was founded as one of the world’s earliest dedicated psychiatric hospitals through a bequest from Jonathan Swift (a Trinity-linked figure). It has evolved into Ireland’s largest independent not-for-profit mental health provider. The modern academic partnership strengthened significantly around 2009 via a Memorandum of Understanding with TCD, formalizing its status as St Patrick’s University Hospital and deepening collaboration on research, training, and clinical services.

stpatricks.ie TCD’s Discipline of Psychiatry has a long tradition dating back to the 19th century, with key figures contributing to Irish and international psychiatry. The hospital serves as a primary clinical and teaching site. Clinical Services SPMHS operates multiple sites:

• St Patrick’s University Hospital (Dublin 8, ~241 beds) — Main adult inpatient and day services.
• St Patrick’s, Lucan (formerly St Edmundsbury, ~52 beds) — Additional adult services.
• Willow Grove Adolescent Unit — Specialist adolescent care.

It provides comprehensive inpatient, day patient, outpatient (including Dean Clinics), homecare, and community services for moderate to severe mental health difficulties. Specialties include:

• General adult psychiatry.
• Psychiatry of later life (old age).
• Anxiety disorders (dedicated programme).
• Mood disorders (including treatment-resistant depression).
• Psychosis recovery.
• Eating disorders.
• Addictions and dual diagnosis.
• Adolescent mental health.
• Psychotherapy and ECT (one of Ireland’s largest ECT services).

Care is delivered by multidisciplinary teams (psychiatrists, nurses, psychologists, CBT therapists, occupational therapists, social workers, pharmacists). The hospital emphasizes recovery-oriented, human rights-based approaches and has consistently high compliance in Mental Health Commission inspections.

stpatricks.ie Anxiety Disorders Programme (highly relevant to your prior interest in anxiety): Established in 2005, this is Ireland’s only specialized anxiety service of its kind. Led by Dr Michael McDonough (Consultant Psychiatrist and Associate Clinical Professor of Psychiatry at TCD), it offers a structured, CBT-focused multidisciplinary programme (group and individual therapy, psychoeducation, mindfulness, occupational therapy elements) across three levels of intensity, plus aftercare. It covers GAD, panic disorder/agoraphobia, social anxiety, specific phobias, OCD, and related conditions. Assessments occur at Dean Clinics; treatment can be inpatient, day patient, or outpatient. Referrals come via GPs or psychiatrists.

stpatricks.ie Teaching and Training SPMHS is a core teaching hospital for TCD. It supports:

• Undergraduate medical education in psychiatry.
• Postgraduate psychiatry training (part of the TCD Deanery for Basic Specialist Training, alongside sites like St James’s and Tallaght).
• Clinical placements for nursing, occupational therapy (recent formal MoU expansion in 2025), psychology, and other disciplines.

Many consultants hold TCD academic titles (e.g., lecturers, senior lecturers, associate professors, clinical professors).

tcd.ie Research and Academic Activities

Research is a major focus through SPMHS’s Academic Institute, which promotes a strong research culture, oversees projects, ensures ethical standards and service-user involvement, and has developed a Research Strategy for 2023–2027. A new SPIRE (St Patrick’s Institutional Research Repository) launched in late 2024/early 2025 as Ireland’s first dedicated mental health research repository (500+ items, including TCD collaborations).

stpatricks.ie Key partnerships include TCD’s School/Discipline of Psychiatry, with additional links to UCD Psychology and UCC Pharmacy. TCD’s Department of Psychiatry collaborates closely with TCIN (neuroimaging, molecular neuroscience, genomics, brain health/ageing) and other Trinity institutes (TTMI, TBSI). This creates a translational pipeline from basic neuroscience to clinical application.

tcd.ie Notable research themes and projects:

• Treatment-resistant/severe depression — including randomized trials of ketamine (KARMA-Dep series, led by Prof Declan McLoughlin) and ECT (EFFECT-Dep, CARE-Dep studies on mechanisms and optimization).
• Molecular biomarkers, mechanisms of action (e.g., ECT effects on microglia/neurogenesis, kynurenine pathway), and neuroimaging/genomics overlaps via TCIN.
• Eating disorders and biological ageing.
• Psychosis, mood disorders, nursing practice/implementation science, and service evaluation.
• Broader work on inflammation, brain stimulation, and recovery.

Key researchers with dual SPMHS/TCD roles:

• Prof Declan McLoughlin — Research Professor of Psychiatry (SPMHS & TCD); also affiliated with TCIN. Leads major depression trials (ketamine and ECT). Expertise in molecular neuroscience, biomarkers, and neuromodulation. His work bridges clinical psychiatry and TCIN neuroscience. tcd.ie
• Prof Paul Fearon — Medical Director (SPMHS) and Clinical Professor of Psychiatry (TCD). Interests in epidemiology, social psychiatry, psychosis, and service quality.
• Dr Michael McDonough — Leads the Anxiety Disorders Programme; Associate Clinical Professor at TCD. Focus on CBT and anxiety disorders.
• Others contribute to mood disorders, psychosis, adolescent psychiatry, and related areas.

International collaborations and funding (e.g., Health Research Board) support this work. Relevance to Psychiatric Conditions and TBI-Related Anxiety

• Anxiety: Direct match via the specialized programme and CBT expertise.
• Broader psychiatry: Strong focus on depression, psychosis, mood disorders, and neurobiological mechanisms (inflammation, brain changes) that overlap with post-TBI psychiatric sequelae (anxiety and depression are common after TBI).
• Neuroscience links: Through TCD/TCIN collaborations (neuroimaging, molecular work), the setup supports research into brain mechanisms underlying psychiatric illness, which has clear relevance to traumatic brain injury effects.
• While not a dedicated TBI centre, the high clinical volume, research infrastructure, and academic-clinical integration make it well-positioned for studies or interventions addressing psychiatric aspects of brain injury.

How This Fits with Trinity/TCIN Bequests (from your prior query)The integrated model (TCD academic oversight + SPMHS clinical base) means bequests supporting TCD’s Institute of Neuroscience, Department of Psychiatry, or specific researchers (e.g., McLoughlin’s depression/neuroscience work) can directly advance psychiatric research with real-world clinical application at St Patrick’s. You could specify interest in anxiety, mood disorders, or neurobiological mechanisms relevant to TBI. Contact TCD Development & Alumni or TCIN/Department of Psychiatry leads to discuss directing funds.Contacts for further information:

• SPMHS general: info@stpatsmail.com or +353 1 249 3200; website stpatricks.ie (research, services, referrals).
• TCD Discipline of Psychiatry: Via tcd.ie/medicine/psychiatry.
• Anxiety Programme specifics or research: Through SPMHS or Dr McDonough’s team.
• Academic Institute/SPMHS research: Check stpatricks.ie/research or SPIRE repository.

This affiliation represents a robust ecosystem for advancing psychiatric care and neuroscience-informed research in Ireland. If you’d like deeper dives into specific researchers, projects, how to engage for a bequest, or related topics (e.g., recent publications), let me know!

7 web pages

Explore the KARMA-Dep ketamine trials

Investigate Trinity’s neuroscience institute

Thought for 31s

Trinity College Institute of Neuroscience (TCIN) is Trinity College Dublin’s dedicated Trinity Research Institute (TRI) and Ireland’s only national neuroscience research institute. It serves as a hub for interdisciplinary basic and translational neuroscience, bridging fundamental science with clinical applications.

tcd.ie Overview and ScaleTCIN brings together approximately 50 Principal Investigators (PIs) and 250 researchers from diverse fields, including Psychology, Psychiatry, Physiology, Pharmacology, Medicine, Biochemistry, Engineering, Genetics, and others. Its core mission is to promote and support interdisciplinary basic and translational research, teaching, public engagement, and national leadership in neuroscience. It addresses questions from molecular processes to complex cognitive systems using preclinical models (cell and animal) alongside human studies.

tcd.ie The institute emphasizes connectivity between basic and applied neuroscience, with a strong focus on translational work that involves patient populations. History and DevelopmentTCIN was founded in 2002 (with an official opening in 2005) to consolidate neuroscience strengths across Trinity and build collaborative teams in translational areas. Neuroscience has been identified as a strategic strength at Trinity. In 2016, it launched the Global Brain Health Institute (GBHI) in partnership with the University of California, San Francisco, supported by a major $170 million+ investment from Atlantic Philanthropies. This significantly boosted focus on cognitive ageing, dementia prevention, and brain health, while recruiting new PIs.

tcd.ie TCIN is celebrating its 25th anniversary around 2025–2026, with plans for an updated strategic plan later in 2025 (following Trinity’s own plan). It has grown substantially in PIs, students, and impact since inception.

Leadership

• Director: Professor Rhodri Cusack (Thomas Mitchell Professor of Cognitive Neuroscience, School of Psychology). His work focuses on neuroimaging, infant cognition development, and clinical applications using brain imaging and AI. tcd.ie
• Deputy Director: Professor Andrew Harkin (Professor in Pharmacology, School of Pharmacy and Pharmaceutical Sciences). He leads the Neuropsychopharmacology Research Group, with interests in stress/inflammation in mental illness, bi-directional nervous-immune interactions, glutamate transmission, and potential anti-inflammatory treatments for psychiatric/neurological disorders. tcd.ie
• GBHI Connections at TCIN: Includes Professor Brian Lawlor (Site Director of GBHI at TCIN and Conolly Norman Professor of Old Age Psychiatry) and founding co-director Professor Ian Robertson.

Facilities and InfrastructureThe administrative and scientific hub is in the Lloyd Building on Trinity’s main campus. It houses advanced TCIN-managed technologies, including:

• Two high-field human and small animal MRI systems.
• A newer Cerca OPM MEG (magnetoencephalography) facility (added around 2025).

Researchers also use preclinical cell/animal models and a wide range of molecular, cellular, biochemical, behavioral, physiological, and genetic technologies. Clinical neuroimaging is supported via the CAMI facility at St James’s Hospital, along with the Wellcome-Trust HRB Clinical Research Facility for trials.

tcd.ie Research Focus and ThemesTCIN supports research across multiple interconnected themes, with a strong emphasis on translation:

• Synapses, Cognition and Behaviour — Brain systems underlying attention, memory, reasoning, and psychological functions; links to neurological conditions from age, injury, or disease.
• Neuropsychiatry and Neurodevelopmental Disorders — Mechanisms of psychiatric and developmental conditions (e.g., psychosis, autism, ADHD, depression); translation to diagnosis and treatment. Includes children’s brain health research on genetics/biology of childhood psychosis, autism, ADHD, depression, and substance abuse.
• Neurodegeneration, Neuroprotection and Neurorepair — Fundamental mechanisms of brain development, response to insult/injury, and targets for prevention/treatment of neurodegenerative diseases and injury-related conditions.
• Other areas: Neural development and plasticity, brain ageing, psychiatric diseases and drug abuse, inflammation/stress in mental illness, and platform technologies (imaging and neural engineering).

Platform strengths include advanced neuroimaging and computational approaches. Research is funded by Science Foundation Ireland (SFI), Wellcome Trust, Health Research Board (HRB), EU/Horizon programmes, philanthropic sources, and industry. Output is high (e.g., 376 papers in 2023, with many interdisciplinary collaborations).

tcd.ie Clinical and Translational Partnerships

TCIN excels at bridging basic science and clinical application. It provides access to patient populations, biosamples, and genotyping through clinical PIs based at:

• St Patrick’s Mental Health Services (psychiatry — strong ties to TCD’s Discipline of Psychiatry).
• St James’s Hospital (including CAMI neuroimaging and clinical trials facility).
• Tallaght University Hospital.

This setup supports translational neuroscience with real-world patient data, directly relevant to psychiatric conditions.

tcd.ie Education, Training, and Public Engagement

• Undergraduate: Interdisciplinary B.A. (Mod.) in Neuroscience.
• Postgraduate: MSc in Neuroscience (Ireland’s only dedicated programme); supports over 80 PhD students.
• Public engagement includes an annual public lecture series, Science Gallery exhibitions, and initiatives with humanities/social sciences (supported by Wellcome Trust funding).
• TCIN fosters early-career development through symposia and events.

Relevance to Psychiatric Conditions, Anxiety, and TBITCIN’s neuropsychiatry theme, clinical links (especially to St Patrick’s psychiatry), and neuroprotection/neurorepair focus align closely with psychiatric disorders and post-traumatic brain injury (TBI) anxiety:

• Neuropsychiatry and neurodevelopmental work covers mechanisms of anxiety, depression, psychosis, and related conditions.
• Inflammation, stress, and molecular mechanisms (e.g., via Deputy Director Andrew Harkin’s group) are relevant to mental illness and TBI sequelae.
• Neuroimaging (MRI/MEG) and translational approaches enable study of brain changes in psychiatric conditions or after injury.
• Neurorepair/neuroprotection themes directly address injury responses and recovery.
• Collaborations with St Patrick’s (including researchers like Prof Declan McLoughlin on depression treatments such as ketamine/ECT) provide clinical depth.
• Broader work on cognition, brain development, and ageing intersects with long-term psychiatric outcomes post-TBI.

While there is no single dedicated “TBI anxiety” programme, the institute’s structure and themes provide an excellent foundation for such research through its interdisciplinary and translational model.

Recent Developments and Impact

• 25th Anniversary activities and upcoming new strategic plan.
• New MEG facility (2025).
• Regular events like Neuroscience Research Days, Young Investigator Symposia, and specialized meetings (e.g., Computational Psychiatry, MEG UKI).
• Strong publication record and funding successes (e.g., major Wellcome Trust awards).
• TCIN has elevated Trinity and Ireland’s international neuroscience reputation to one of Europe’s leading centres.

Engagement and BequestsTCIN is well-positioned for philanthropic support (including bequests) due to its translational impact, clinical partnerships, and interdisciplinary strengths. Bequests to Trinity can be directed specifically to TCIN or priority areas (e.g., neuropsychiatry, neuroprotection, or anxiety-related mechanisms) via Trinity Development & Alumni.

Key contacts:

• TCIN: neuroscience@tcd.ie or +353 1 896 8484 (Lloyd Building).
• Director: Rhodri Cusack (cusackrh@tcd.ie).
• Deputy Director: Andrew Harkin (aharkin@tcd.ie).
• For legacies/donations: alumni@tcd.ie or tcd.ie/alumni (mention TCIN or specific research interests).

TCIN represents a dynamic, collaborative environment where basic neuroscience meets clinical psychiatry and brain injury research, making it a strong candidate for targeted support in areas like psychiatric conditions and post-TBI anxiety. If you need deeper details on specific PIs, projects, publications, or assistance with bequest wording/contacts, provide more details!

4 web pages

Explore Global Brain Health Institute

Investigate Trinity’s School of Psychology

Thought for 26s

The Global Brain Health Institute (GBHI) is a pioneering international initiative dedicated to reducing the scale and impact of dementia while advancing brain health equity worldwide. It emphasizes a life-course approach to brain health—viewing it as shaped by lifelong social, environmental, and biological factors rather than solely the absence of disease.

Founding and History

GBHI was established in 2015 through a landmark gift from The Atlantic Philanthropies (its largest-ever program grant, approximately $177 million / €138.4 million). This funded a groundbreaking partnership between the University of California, San Francisco (UCSF) and Trinity College Dublin (Trinity).

atlanticphilanthropies.org The initiative was one of Chuck Feeney’s (Atlantic’s founder) final major “bets,” reflecting his commitment to bold, long-term solutions for global challenges. It launched formally around 2016 with the goal of training at least 600 global leaders over 15 years in research, healthcare delivery, policy, and advocacy to combat the dementia epidemic. By 2050, dementia cases are projected to triple to 152 million, with enormous costs to individuals, families, and economies.

gbhi.org GBHI is one of seven Atlantic Fellows programs focused on equity and social change. It marked its 10-year milestone in 2025–2026 with events at Trinity, including the inaugural Chuck Feeney Lecture on “Brain health, equity, and our shared planet.”

Mission and Core Approach

GBHI works to protect aging populations from threats to brain health, with a strong emphasis on equity—particularly for medically, economically, and educationally disadvantaged communities. It operates through three interconnected pillars:

1. Training and connecting leaders via the Atlantic Fellows for Equity in Brain Health program.
2. Expanding evidence-based preventions and interventions.
3. Sharing knowledge through advocacy, education, and global networks.

It adopts an interdisciplinary, values-based model drawing from neuroscience, public health, policy, economics, arts/humanities, and more. The focus includes social determinants of health, prevention across the lifespan, and addressing inequities in dementia care and brain health outcomes.

gbhi.org Leadership

• Trinity Site:
  • Founding Director: Professor Brian Lawlor (Conolly Norman Professor of Old Age Psychiatry at Trinity; remains active in strategy, training, and mentorship).
  • Site Director (effective January 2025): Professor Iracema Leroi (Professor in Geriatric Psychiatry at Trinity; Consultant Psychiatrist at St James’s Hospital; leads HRB-CTN Dementia Trials Ireland). She advances a life-course, interdisciplinary vision.
• Previous: Professor Ian Robertson served as a founding co-director (stepped down in 2024).
• UCSF side includes complementary leadership (e.g., Victor Valcour as Site Director in recent reports).

Faculty expertise spans neurodegeneration, mental health, aging, dementia prevention, health economics, policy, technology, and arts in health.

gbhi.org Key Programs and Activities

Atlantic Fellows for Equity in Brain Health (flagship program):

• 12-month residential fellowship based at either UCSF or Trinity.
• Open to diverse professionals (clinicians, researchers, policymakers, artists, journalists, etc.) from around the world.
• Curriculum covers neurology, epidemiology, health economics, law/ethics, leadership, policy, creativity, and research methods.
• Includes mentorship, networking, and opportunities for pilot projects.
• Over 300 fellows from 65+ countries; strong alumni network.
• Pilot Awards for Global Brain Health Leaders: Competitive small grants (~$25,000) for fellows’ innovative projects. These have leveraged tens of millions in additional funding and supported work in 45+ countries.

Research and Interventions:

• Projects like PREVENT-Dementia (early detection and prevention; multi-center study with Trinity leadership).
• Focus areas include caregiver burden, end-of-life care in dementia, social determinants of healthy aging (e.g., Latin America studies), sensory-cognitive links (hearing/vision), and emerging threats like climate change.
• GBHI Projects: Larger faculty-led initiatives for training and scalable impact.

Advocacy and Knowledge Sharing:

• Regional convenings, publications, media engagement, and policy influence (e.g., supporting national dementia plans).
• Emphasis on creativity (e.g., arts in brain health) and global equity.

Trinity Connection and Integration

GBHI is housed within Trinity’s Institute of Neuroscience (TCIN), creating strong synergies with broader neuroscience research. It links closely to clinical psychiatry via leaders like Professors Lawlor and Leroi (St James’s Hospital) and aligns with Trinity’s strengths in geriatric psychiatry, cognitive neuroscience, and translational work. This builds on Trinity’s historical ties to psychiatric care (e.g., St Patrick’s) and complements TCIN’s focus on neuropsychiatry, neuroprotection, and brain health.Impact and Scale

• Global network spanning 65+ countries.
• Pilot projects have secured significant leveraged funding (tens of millions) and produced publications, media coverage, and real-world interventions.
• Fellows and projects address prevention, care models, equity, and policy in diverse contexts.
• High-profile support and events, including recent 10-year celebrations with Irish leaders and international figures.

Relevance to Broader Context (Psychiatry, Anxiety, TBI)

GBHI’s dementia/brain health focus overlaps with psychiatric conditions (e.g., late-life depression, anxiety in aging or neurodegenerative disease, caregiver mental health). Its life-course and equity lens could extend to prevention or mitigation of psychiatric sequelae after traumatic brain injury (TBI), inflammation/stress pathways, or cognitive/mental health resilience. The institute’s clinical ties (via St James’s and Trinity psychiatry) and interdisciplinary model make it relevant for translational work bridging neuroscience, psychiatry, and brain injury recovery.

Engagement and Opportunities

• Fellowship applications: Annual cycles; details at gbhi.org/apply (Trinity or UCSF tracks).
• Explore fellows, projects, and impact at gbhi.org.
• Philanthropic support: As a major Atlantic-funded initiative, GBHI exemplifies how targeted giving advances brain health research and leadership. Bequests or donations to Trinity/TCIN can support related efforts (contact Trinity Development & Alumni).

GBHI represents a transformative, equity-driven model for addressing one of the 21st century’s biggest health challenges through leadership development and global collaboration. It strengthens Trinity’s position as a neuroscience and brain health hub.If you’d like deeper details on specific programs, fellows’ work, research projects (e.g., PREVENT), leadership transitions, or how it connects to bequests/TCIN/St Patrick’s psychiatry, let me know!

Explore PREVENT-Dementia study details

Learn about Atlantic Philanthropies history

Explore PREVENT-Dementia study details

Thought for 36s

PREVENT-Dementia (also styled as the PREVENT dementia programme) is a major multi-centre prospective cohort study focused on identifying midlife risk factors for dementia (particularly Alzheimer’s disease) and detecting the earliest preclinical indices of neurodegenerative disease—often decades before clinical symptoms appear. It targets midlife (roughly ages 40–59) as a critical “window of opportunity” for prevention and early intervention.

tcd.ie Aims and Rationale

The core goals are to:

• Profile modifiable and non-modifiable midlife risk factors for later-life neurodegeneration.
• Identify and describe the earliest brain changes (biomarkers) heralding dementia, especially Alzheimer’s.
• Enable early detection, risk stratification, timely interventions (pharmacological and non-pharmacological), and development of novel treatments.
• Advance understanding of how and when to intervene to reduce risk, support early diagnosis, and inform population-level prevention strategies.

It is one of the pioneering epidemiological initiatives emphasizing midlife intervention in neurodegenerative conditions, with a strong emphasis on deep phenotyping (detailed biological, imaging, cognitive, and lifestyle profiling) in cognitively healthy but at-risk individuals.

pmc.ncbi.nlm.nih.gov

History, Sites, and Collaborations

• Initiated: 2014 as a single-site study in West London (led by Craig Ritchie and colleagues).
• Expansion: Grew into a multi-centre study with sites in Edinburgh (2015), Oxford (2017), Cambridge (2017), and Dublin (2018).
• Dublin/Trinity Site: Led by GBHI faculty members Professor Lorina Naci (Dublin co-lead; Trinity College Institute of Neuroscience and Global Brain Health Institute) and Professor Brian Lawlor (Founding Director, GBHI at Trinity; Conolly Norman Professor of Old Age Psychiatry). It operates in close collaboration with St James’s Hospital.
• Broader Network: Involves researchers from Cambridge, Oxford, Edinburgh, Imperial College London, and INSERM Neuroscience (France). It serves as a research, training, and education platform for Atlantic Fellows in the Global Brain Health Institute (GBHI), with 15+ fellows involved.
• Recent activity includes hosting the PREVENT General Assembly in Dublin, bringing together global experts. tcd.ie

Study Design and Methodology

PREVENT is a longitudinal prospective cohort study. Participants are cognitively healthy adults (screened via Addenbrooke’s Cognitive Examination-III) aged 40–59, often with elevated risk (e.g., parental family history of dementia or APOE ε4 genotype).Core Assessments (baseline and follow-ups):

• Demographic, Lifestyle, and Psychological Data: Questionnaires on physical activity, diet, sleep, depression/anxiety (e.g., CES-D, STAI), resilience, stressful events, and traumatic brain injury history.
• Cognitive Testing: Comprehensive battery including computerized tasks (COGNITO for attention/memory/visuospatial/language), virtual reality/spatial navigation tasks (e.g., Four Mountains Test, Virtual Supermarket Trolley for path integration), and global screening (ACE-III).
• Neuroimaging: Multi-modal 3T MRI (structural: T1/T2/FLAIR/SWI; functional: resting-state and task-based fMRI; diffusion tensor imaging; arterial spin labelling; spectroscopy). Processed for volumetrics (e.g., hippocampus), cortical thickness, white matter hyperintensities, and more.
• Biological Samples: Blood, saliva (including stress-response), urine; optional cerebrospinal fluid (CSF) via lumbar puncture. Genetic analysis (APOE genotyping and genome-wide).
• Sub-Studies: Amyloid/tau PET imaging, virtual reality assessments, eye/hearing/dental evaluations, and others.

Recruitment: Via memory clinic relatives, dementia research registers (e.g., Join Dementia Research), word-of-mouth, and the study website (preventdementia.co.uk). Family/friends often invited. No geographic restrictions for some sites.Timeline: Baseline (2014–2020 across sites); follow-ups (e.g., ~2 years, then 5–8 years). Dublin site is in its later phases (first follow-ups concluding; plans for continued assessment).

pmc.ncbi.nlm.nih.gov Participants and Baseline Characteristics

• Cohort Size: ~700 deeply phenotyped participants across sites (with substantial data from Dublin).
• Demographics (baseline summary): Mean age ~51 years; ~62% female; highly educated (mean ~16.7 years); predominantly European ancestry.
• Risk Profiling: Roughly equal split with/without parental dementia history. ~38% APOE ε4 carriers (including homozygotes). Categorized into low/medium/high risk groups. High prevalence of modifiable risks (e.g., overweight/obesity, physical inactivity, poor sleep, head injury history, hypertension).
• Baseline data (published 2024 in Brain Communications) describe the cohort in detail and are openly shared via platforms like the Alzheimer’s Disease Data Initiative (ADDI). pmc.ncbi.nlm.nih.gov

Funding and Support

• Core Funding: Alzheimer’s Society (UK) from 2014.
• Dublin/Trinity: GBHI provided a €250,000 project grant in 2017 (to Naci and Lawlor) to initiate the site. Naci has since secured ~€1 million in additional competitive funding. In 2024, she received an HRB Individual Led Project award (€450,000) to extend the Dublin study into its eighth year (Trinity/St James’s).
• Additional/Sub-Studies: UK Medical Research Council, US Alzheimer’s Association, industrial partners (~£2.9 million leveraged). The programme has enabled related work (e.g., sports head injury cohorts funded by English Football Association/FIFA).
• Overall, PREVENT has attracted substantial investment and serves as a platform for further grants. tcd.ie

Key Findings and Outputs

• Baseline Data (2024): Comprehensive description of the midlife cohort; subtle brain changes detectable in middle age among at-risk individuals. Data shared openly to accelerate research.
• Recent Trinity-Led Insights (part of PREVENT): Engaging in physically, socially, and intellectually stimulating midlife activities (e.g., playing piano, foreign travel, socializing with friends) significantly boosts cognition—even in those with genetic or familial Alzheimer’s risk. This highlights modifiable lifestyle factors as powerful protective elements decades before typical onset.
• Other outputs: Novel insights into early biomarkers (imaging, cognition, navigation/spatial tasks via VR), risk factor interactions, and preclinical Alzheimer’s changes. Over 40 publications; high-impact contributions to the field.
• Broader Context: Aligns with global efforts (e.g., Lancet Commission on dementia prevention) emphasizing modifiable risks like traumatic brain injury (TBI), hypertension, and lifestyle. tcd.ie

Current Status and Future Directions

• Ongoing: Longitudinal follow-ups continue; Dublin site actively building its dataset with preclinical biomarker assessments. Sub-studies (e.g., PET imaging, sensory assessments, athlete cohorts) are active or expanding.
• Data Sharing: Baseline data available via ADDI and other platforms; imaging and code increasingly shared to support wider research.
• Impact: Platform for GBHI Atlantic Fellows training; awareness-raising in Ireland; contributions to early-detection tools and prevention strategies. Expected to inform when and how to intervene (e.g., lifestyle or emerging therapies).
• Challenges noted in publications include cohort demographics (highly educated, less ethnic diversity than general population) and the value of longer-term follow-up for symptomatic outcomes.

Relevance to Broader Brain Health Context

PREVENT complements GBHI’s focus on dementia prevention, equity, and life-course brain health. Its Trinity leadership (Naci in neuroscience/psychology; Lawlor in old age psychiatry) links directly to TCIN (imaging, cognition, neurodegeneration) and clinical psychiatry (St James’s). It addresses modifiable risks relevant to psychiatric conditions (e.g., depression, anxiety as risk factors) and post-TBI outcomes (TBI is a recognized dementia risk factor; lifestyle interventions may support resilience). The emphasis on early biomarkers and prevention aligns with translational neuroscience goals.For the latest details, visit preventdementia.co.uk or search recent publications (e.g., the 2024 Brain Communications baseline paper). Data requests are possible via the study’s steering processes.If you need specifics on a sub-study, particular findings, how it relates to bequests/TCIN/GBHI, or comparisons to other prevention trials, let me know!

3 web pages